Stoic VC
Venture capitalSydney · Pre-Seed–Series A · 5 people tracked
Investment thesis
Stoic backs scientists and engineers commercialising research from leading Australian universities, aiming to turn breakthrough science into commercially viable, high-velocity technologies. It focuses on three areas: human health (products advancing standard of care), advanced computing (next-generation processing and computational systems), and the physical world (addressing environmental challenges). The firm typically enters after a startup has demonstrated proof of concept of its research, writing first cheques from roughly A$100K to A$1M. Partnered with Uniseed since 2019, it offers founders direct access to investors, operators and academics, drawing on decades of commercialisation experience and connections across ten of Australia's top research institutions.
Source: firm website, verified Aug 3, 2026.
Team · 5 people
from the firm's website
What they invest in
from 17 of 25 portfolio companiesHealthtech ×10Biotech ×8Medical Devices ×5Digital Health ×4Hardware ×3IoT ×3Deep Tech ×2AgTech ×1
HQs:Australia×7United States×1
Investments · 25 tracked
founders shown can be your intro path
Kinoxis Therapeutics develops small-molecule drugs for disorders of the brain and mind, including its lead candidate KNX100 for agitation associated with dementia, substance use disorders (such as alcohol and opioid withdrawal), and chronic pain.
BiotechHealthtechMelbourne, AU
Co-investorsUniSeed Pty Ltd.
Axelia Oncology develops cancer immunotherapies that activate the body's innate immune system, with a lead candidate, AXA-042, a systemically-delivered TLR2/6 agonist aimed at checkpoint-insensitive solid tumors.
BiotechHealthtech
Preventing airborne diseases in agriculture with cutting-edge technology that helps farmers proactively manage crops.
BioScout provides autonomous, solar-powered air sampling devices that detect and identify airborne fungal spores, combining live spore counts with weather data to give growers, agronomists, and agrochemical distributors disease-risk intelligence for fungicide spray timing.
AgTechAI & Machine LearningDeep TechHardwareIoT
Lewis Collins(CEO)
Co-investorsArtesianUniSeed Pty Ltd.
Cardiovascular disease improvement solutions
Cardihab offers a digital therapeutic platform for cardiac rehabilitation, providing a clinician portal, patient apps, and integrated telehealth for remote monitoring and personalised virtual care plans.
Digital HealthHealthtechMedical Devices
Co-investorsUniSeed Pty Ltd.
Certa Therapeutics is a biotech company developing anti-fibrotic therapies for serious fibrotic diseases such as systemic sclerosis and chronic kidney disease.
BiotechHealthtech
Co-investorsUniSeed Pty Ltd.
ENA Respiratory is a clinical-stage pharmaceutical company developing antiviral host defense enhancers intended to prevent severe complications from respiratory viral infections in at-risk, vulnerable populations.
BiotechHealthtech
Co-investorsBrandon BioCatalystUniSeed Pty Ltd.
Exonate is a biotechnology company developing treatments for retinal vascular diseases, with a lead asset (EXN407) intended as a topical therapy for diabetic retinopathy and diabetic macular oedema.
BiotechDigital HealthHealthtechMedical Devices
Olav Hellebø(Chief Executive Officer)
Co-investorsO2h VenturesWellcome TrustWren CapitalCambridge Angels groupEMV CapitalMartlet Capital+1 more
Ferronova develops magnetic iron-oxide nanoparticle tracers (FerroTrace) and related imaging and therapy technologies to detect and map lymph nodes and tumours in early-stage cancers, supporting surgeons, oncologists and pathologists in staging and treating cancers such as oral, colorectal, esophageal, prostate and pancreatic.
BiotechHealthtechMedical Devices
Benjamin Thierry(Scientific Advisor/Founder)Stewart Bartlett(CEO)Anil Shetty(CMO)
Co-investorsArtesianSouth Australian Venture Capital FundBooster Innovation FundMatūUniSeed Pty Ltd.
Developing next generation therapeutics for behavioural and cognitive disorders.
Smart prevention and patient monitoring solution for pressure ulcers
Lenexa Medical develops LenexaCARE, a technology that provides clinicians with data on patient position, posture, and presence to prevent pressure injuries and detect falls.
Digital HealthHealthtechMedical Devices
Co-investorsMedTech Actuator
Morse Micro designs Wi-Fi HaLow (IEEE 802.11ah) system-on-chip semiconductors that provide long-range, low-power sub-1 GHz wireless connectivity for IoT devices such as security cameras, dongles, and access points.
HardwareIoTSemiconductorsSydney, AU
Andrew Terry(Co-founder & CTO)inMichael De Nil(Co-founder & CEO)inJoe Bedewi(Chief Financial Officer)in
Co-investorsMain Sequence VenturesBlackbird VenturesRight Click CapitalSpringCapital InvestmentVirescent VenturesStartmate+1 more
NatureHelm is a biodiversity intelligence platform that aggregates remote sensing and ground-based species data to help corporations, financial institutions, and primary producers assess and report nature-related risks, impacts, and dependencies.
Climate TechData & InfrastructureSaaS
Dr Debbie Saunders(Co-founder, Conservation Ecologist & CEO)Phil Keaton(Co-founder, Innovative Technology & CPO)Alexandra Kmita(CMO)
Neurode develops a wearable neurostimulation headband paired with a companion app that provides personalized insights and recommendations from psychologists, neuroscientists, and engineers.
Digital HealthHardwareMental Health
Co-investorsPsyMed Ventures
Therapies for fibrotic and inflammatory diseases associated with diabetes complications
Co-investorsBrandon BioCatalystBrandon Capital Partners
PERKii makes probiotic drinks using a micro-shielding technology designed to protect probiotics from stomach acid for targeted release in the gut, marketed to support immune function and gut health.
ConsumerFoodTechWellness & Fitness
Co-investorsBrisbane Angels
Q-Sera develops RAPClot, a recombinant ecarin-based clotting formulation used in rapid serum blood collection tubes.
BiotechHealthtechMedical Devices
Co-investorsUniSeed Pty Ltd.
Clinical-stage biotech developing Q-122, an orally bioavailable small molecule for treating endocrine therapy-induced hot flashes in breast cancer patients.
Co-investorsBrandon BioCatalyst
Que Oncology develops non-hormonal therapies for moderate to severe vasomotor symptoms in postmenopausal women and in cancer patients undergoing hormone therapy.
BiotechFemTechHealthtech
Co-investorsBrandon BioCatalyst
Portfolio news
latest coverage across their companiesUniseed · smartcompany.com.au · Apr 17, 2026
Ferronova · ferronova.com.au · Dec 17, 2025
Morse Micro · computerweekly.com · Sep 23, 2025
PERKii · uniquest.com.au · May 25, 2025
Frequently asked questions
- How many investments has Stoic VC made?
- Stoic VC has 25 tracked investments.
- What stage does Stoic VC invest at?
- Stoic VC invests at the Pre-Seed, Seed, Series A stages.
- What is Stoic VC's typical check size?
- Stoic VC typically writes checks of $65K – $650K.
- What sectors does Stoic VC focus on?
- Stoic VC focuses on AgTech, AI & Machine Learning, Biotech, Cleantech, Climate Tech, Deep Tech, Healthtech, Medical Devices.
- Where is Stoic VC located?
- Stoic VC is headquartered in Sydney, AU.
- Does Stoic VC lead rounds?
- Stoic VC typically participates in rounds rather than leading them.
- Who does Stoic VC co-invest with?
- Stoic VC most often shares deals with Brandon BioCatalyst, Blackbird Ventures, EMV Capital, among 14 tracked co-investors.
Similar investors
Future Positive Capital is a European deep-tech fund that ties its entire thesis to the Future Cones foresight framework, explicitly focusing on preferable futures and positioning itself as a futures-thinking, systems-change VC rather than a generic climate or impact fund. The firm hard-wires impact into its economics by contractually indexing more than 100% of partners' carried interest to portfolio companies achieving both financial and measurable impact outcomes, while specializing in capital-intensive, highly technical step-change solutions for planetary-scale problems like robotics for wind farm operations, large-scale carbon removal, and ecosystem restoration.
Innovestor is a Finnish investment manager active in venture capital, real estate, and energy storage, and also provides corporate venturing services.
Voima Ventures is a deep tech venture capital firm that backs founders building global solutions across people, planet, and industry, from technology spin-offs to scaling companies.
Oxford Science Enterprises (OSE) is an investment company that funds and scales spinouts arising from research at Oxford, Harwell and Culham, partnering with researchers to co-create ventures across deep tech, life sciences and healthtech.
Innovobot is an investment and innovation platform focused on deep tech, combining a venture fund (IRV), an innovation studio (Innovobot Labs), and engineering services to foster technologies that address social, industrial and environmental challenges.